Automatic Website Traffic RSS

Phase 2 trial testing dazucorilant in ALS patients now fully enrolled

A Phase 2 clinical trial testing Corcept's cortisol modulator dazucorilant in adults with sporadic or familial ALS is now fully enrolled. read more

Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients

Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients ... read more

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute ... read more

EQS-News: CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK. Phase 1 part of combined Phase 1/2 study initiated as part of ... read more

Curium Enrolls First Prostate Cancer Patients in its Phase 3 SOLAR Trials

The first trial is SOLAR-STAGE: a Phase 3, multicenter, open-label study to evaluate the diagnostic performance of copper Cu 64 PSMA I&T PET/CT in staging of men with newly diagnosed unfavorable ... read more

Roche’s pipeline rethink hits 20% of new molecules as cancer candidates join discard pile

The culls are part of a broader refocusing that has removed 20% of new molecules from the pipeline in recent quarters. read more

Kalazar Drug Enters Phase Two Clinical Trials in Ethiopia

The Kalazar treatment drug has reached an exciting milestone as it enters the crucial phase two clinical trials in Ethiopia. This development brings renewed hope for the effective and patient-friendly ... read more

Austal completes sea trials for Australia's autonomous patrol boat project

Australian shipbuilder Austal has completed the sea acceptance trials phase for the country's Patrol Boat Autonomy Trial (PBAT), the company announced on 23 April. read more

Promising Patient-Friendly Oral Drug Against Visceral Leishmaniasis Enters Phase II Clinical Trial in Ethiopia [press release]

The new molecule has the potential to revolutionize treatment for the deeply neglected and hard-to-treat disease, as the Eastern Africa region charts the way to its elimination.An innovative, safer, ... read more

Clinical trial for oral treatment against Kala-azar enters phase II

A new drug to treat visceral leishmaniasis commonly known as Kala-azar has entered Phase II clinical development. The trial of the innovative, safer, simpler, patient-friendly oral medicine is being ... read more